David R. Holmes, MD, Michael J

Slides:

Advertisements

Similar presentations

David R. Holmes, MD, FACC, Michael J

Advertisements

Volume 1, Issue 2, Pages (April 2017)

Intracardiac Echocardiography: A New Guiding Tool for Transcatheter Aortic Valve Replacement Thomas Bartel, MD, Nikolaos Bonaros, MD, Ludwig Müller,

David R. Holmes, MD, Michael J

Late Surgical Explantation and Aortic Valve Replacement After Transcatheter Aortic Valve Implantation Louis W. Wang, MBBS, MM, Emily K. Granger, MBBS,

Annual Outcomes With Transcatheter Valve Therapy

Annual Outcomes With Transcatheter Valve Therapy

The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Graft Operation: A PARTNER Trial Subgroup Analysis

Intracardiac Echocardiography: A New Guiding Tool for Transcatheter Aortic Valve Replacement Thomas Bartel, MD, Nikolaos Bonaros, MD, Ludwig Müller,

Edo Bedzra, MD, MBA, Creighton W. Don, MD, Mark Reisman, MD, Gabriel S

Real-Time Magnetic Resonance–Guided Aortic Valve Replacement Using Engager Valve Bogdan A. Kindzelski, BS, Ming Li, PhD, Dumitru Mazilu, PhD, Timothy.

Transcatheter Aortic Valve Replacement

Transcatheter Valve Implantation in Mitral Annular Calcification During Open Surgery: Extended Collar Technique Michael Ghosh-Dastidar, MBBS, FRCSCTh,

Accurate Localization of Mitral Regurgitant Defects Using Multiplane Transesophageal Echocardiography Gary P. Foster, Eric M. Isselbacher, Geoffrey A.

Arman Kilic, MD, Mary A. Siki, BS, Wilson Y. Szeto, MD, Joseph E

Hybrid Transcatheter-Surgical Strategy in Arterial Tortuosity Syndrome

Ourania Preventza, MD, James J. Livesay, MD, Denton A

David R. Holmes, MD, FACC, Michael J

Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting John V. Conte, MD, Thomas G. Gleason, MD, Jon.

Transatlantic editorial on transcatheter aortic valve replacement

Management of Type A Aortic Dissection and a Large Pheochromocytoma: A Surgical Dilemma Frank W. Bowen, MD, Jessie Civan, BS, Anton Orlin, BS, Thomas.

Surgical Removal and Replacement of Chronically Implanted Transcatheter Aortic Prostheses: How I Teach It Abeel A. Mangi, MD, Mahesh Ramchandani, MD,

Isolated Papillary Muscle Rupture Complicating Acute Pancreatitis

Norihiro Kondo, MD, Takashi Shuto, MD, Jeremy R. McGarvey, MD, Kevin J

Pranav Loyalka, MD, Kelsey B. Montgomery, BS, Tom C

Sapien XT Transcatheter Mitral Valve Replacement Under Direct Vision in the Setting of Significant Mitral Annular Calcification Takashi Murashita, MD,

Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,

Use of the Lotus Transcatheter Valve to Treat Severe Native Aortic Regurgitation Smriti Saraf, MD, Muhammed Zeeshan Khawaja, MD, Roland Hilling-Smith,

Transcatheter Aortic Valve Replacement Has Improved Short-Term but Similar Midterm Outcomes in Isolated Aortic Valve Replacement After Prior Coronary.

Chronic Atrial Fibrillation Is Associated With Reduced Survival After Aortic and Double Valve Replacement Richard Schulenberg, MD, Polychronis Antonitsis,

Transcatheter Closure of Congenital Perimembranous Ventricular Septal Defect in Children Using Symmetric Occluders: An 8-Year Multiinstitutional Experience

Faisal H. Cheema, MD, Elbert E. Heng, Atiq Rehman, MD

Transapical Transcatheter Valve-in-Valve Implantation for Deteriorated Mitral Valve Bioprostheses Manuel Wilbring, MD, Konstantin Alexiou, MD, Sems Malte.

The Progression of a Transcatheter Aortic Valve Program: A Decision Analysis of More Than 680 Patient Referrals Joseph E. Bavaria, MD, Wilson Y. Szeto,

Transapical Aortic Valve Implantation Without Angiography: Proof of Concept Enrico Ferrari, MD, Christopher Sulzer, MD, Carlo Marcucci, MD, Elena Rizzo,

Surgical intervention for complications of transcatheter dilation procedures in congenital heart disease Doff B McElhinney, MD, V.Mohan Reddy, MD, Phillip.

2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry Frederick L. Grover, MD, Sreekanth.

Marek Polomsky, MD, Konstantinos P. Koulogiannis, MD, Robert M

Evolut R Implantation to Treat Severe Pure Aortic Regurgitation in a Patient With Mitral Bioprosthesis Giuseppe Bruschi, MD, Paola Colombo, MD, PhD,

Impact of Intraoperative Transesophageal Echocardiography on Surgical Decisions in 12,566 Patients Undergoing Cardiac Surgery Holger K. Eltzschig, MD,

Jeffrey E. Keenan, MD, John P. Vavalle, MD, Asvin M

Ritu Sachdeva, MD, Richard T. Fiser, MD, William R

Timothy Lee, BS, Alexander J. C

Mathieu Vergnat, MD, Melissa M. Levack, MD, Benjamin M

Surgical management of valvular disease in patients requiring left ventricular assist device support Vivek Rao, MD, PhD, James P Slater, MD, Niloo M.

Brian A. Bruckner, MD, Limael E

Reoperative innominate arterial, ascending aortic, and root replacement for extensive fungal endocarditis Bradley G. Leshnower, MD, Thomas G. Gleason,

Monobloc aorto-mitral homograft as a treatment of complex cases of endocarditis Jean-François Obadia, MD, PhDa, Olivier Raisky, MDa, Laurent Sebbag, MDa,

Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral Thomas G. Gleason, MD,

Reversal of Flow in the Mammary Artery to Treat Subclavian Steal Syndrome in Conjunction With Coronary Bypass Surgery Alexander John, MD, Steffen Hofmann,

Transcatheter Mitral “Valve-in-Ring” Implantation: A Word of Caution

Compassionate aortic valve implantation for severe aortic regurgitation Gregory Ducrocq, MD, Dominique Himbert, MD, Ulrik Hvass, MD, Alec Vahanian, MD

Unusual Cause of Femorofemoral Cardiopulmonary Bypass Failure

Fitsum Lakew, MD, Paul P. Urbanski, MD, PhD

Alice Wang, MD, Thomas A. D'Amico, MD, Mark F. Berry, MD

Aortic Translocation for the Management of Double-Outlet Right Ventricle and Pulmonary Stenosis With Dextrocardia: Technique to Avoid Coronary Insufficiency

Transcatheter Aortic Valve Implantation in a Lung Transplant Recipient

The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States

David J. Kaczorowski, MD, Y. Joseph Woo, MD

United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex Lars G. Svensson, MD, PhD, Todd Dewey,

Reoperative Transapical Aortic Valve Implantation for Early Structural Valve Deterioration of a SAPIEN XT valve Philipp Kiefer, MD, Joerg Seeburger,

Commentary: When a choice is not an echo

Pediatric Coronary Artery Bypass After Arterial Switch Operation: Noninvasive Evaluation With ECG-Gated 64-Slice CT in Routine Practice Monia Jemmali,

Racing to the Rubicon Michael J. Reardon, MD, Vinod H. Thourani, MD

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

The Annals of Thoracic Surgery

TAVI for Pure Aortic Valve Insufficiency in a Patient With a Left Ventricular Assist Device Giuseppe D'Ancona, MD, PhD, Miralem Pasic, MD, PhD, Semih.

Resolution of Heart Block After Surgical Correction of Failed Transcatheter Aortic Valve Implantation Alexander Weymann, MD, Nikhil Prakash Patil, MRCS,

Successful Transapical Implantation of an Edwards Sapien Valve Within an Insufficient Aortic CoreValve Prosthesis: An Initial Experience Simone Schleger,

Presentation transcript:

2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement David R. Holmes, MD, Michael J. Mack, MD, Sanjay Kaul, MBBS, Arvind Agnihotri, MD, Karen P. Alexander, MD, Steven R. Bailey, MD, John H. Calhoon, MD, Blase A. Carabello, MD, Milind Y. Desai, MBBS, Fred H. Edwards, MD, Gary S. Francis, MD, Timothy J. Gardner, MD, A. Pieter Kappetein, MD, PhD, Jane A. Linderbaum, MS, CNP, Chirojit Mukherjee, MD, Debabrata Mukherjee, MD, Catherine M. Otto, MD, Carlos E. Ruiz, MD, PhD, Ralph L. Sacco, MD, Donnette Smith, James D. Thomas, MD The Annals of Thoracic Surgery Volume 93, Issue 4, Pages 1340-1395 (April 2012) DOI: 10.1016/j.athoracsur.2012.01.084 Copyright © 2012 The Society of Thoracic Surgeons, the American College of Cardiology Foundation, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions Terms and Conditions

Fig 1 Sapien Valve. Source: Edwards Lifesciences. The Annals of Thoracic Surgery 2012 93, 1340-1395DOI: (10.1016/j.athoracsur.2012.01.084) Copyright © 2012 The Society of Thoracic Surgeons, the American College of Cardiology Foundation, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions Terms and Conditions

Fig 2 CoreValve. The Medtronic CoreValve System is currently limited to investigational use in the United States. Source: Medtronic, Inc. The Annals of Thoracic Surgery 2012 93, 1340-1395DOI: (10.1016/j.athoracsur.2012.01.084) Copyright © 2012 The Society of Thoracic Surgeons, the American College of Cardiology Foundation, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions Terms and Conditions

Fig 3 PARTNER Trial Design. The Annals of Thoracic Surgery 2012 93, 1340-1395DOI: (10.1016/j.athoracsur.2012.01.084) Copyright © 2012 The Society of Thoracic Surgeons, the American College of Cardiology Foundation, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions Terms and Conditions

Fig 4 Benefit/Risk Balance in the PARTNER Trial. Data are shown for every 1,000 patients treated with TAVR instead of standard treatment in Cohort B (above) or standard AVR in Cohort A (below). The excesses listed are not mutually exclusive, because some patients had more than 1 event. Only data with statistically significant differences at 1 year of follow-up are shown except for deaths* (p=0.44) and atrial fibrillation† (p=0.07) in Cohort A. AR indicates aortic valvular regurgitation; AVR, surgical aortic valve replacement; and TAVR, transcatheter aortic valve replacement. The Annals of Thoracic Surgery 2012 93, 1340-1395DOI: (10.1016/j.athoracsur.2012.01.084) Copyright © 2012 The Society of Thoracic Surgeons, the American College of Cardiology Foundation, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions Terms and Conditions

Fig 5 Reconstructed Multidetector Computed Tomographic Images of the Abdominal Aorta and Its Pelvic Branches Demonstrating Tortuosity and Extensive Calcific Atherosclerosis. The extent and degree of peripheral arterial disease is essential in determining the feasibility and safety of transfemoral approaches. In some patients with extensive disease, alternative approaches such as direct aortic, subclavian, or transapical procedures should be considered. The Annals of Thoracic Surgery 2012 93, 1340-1395DOI: (10.1016/j.athoracsur.2012.01.084) Copyright © 2012 The Society of Thoracic Surgeons, the American College of Cardiology Foundation, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions Terms and Conditions

Fig 6 Midesophageal Long-Axis TEE View Showing the Proper Positioning of a Sapien Valve (black line*) Across the Aortic Annulus Prior to Balloon Deployment. Note that approximately half the valve is above and below the annulus. Note also the difficulty of imaging due to shadowing from the prosthesis and annular and mitral valve calcification, as well as a prominent reverberation artifact, emphasizing the need for thorough training prior to providing procedural guidance. LA indicates left atrium. *Visible as black line. The Annals of Thoracic Surgery 2012 93, 1340-1395DOI: (10.1016/j.athoracsur.2012.01.084) Copyright © 2012 The Society of Thoracic Surgeons, the American College of Cardiology Foundation, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions Terms and Conditions

Fig 7 Mixed AR. Central and paravalvular AR following TAVR deployment in a biplane long- and short-axis TEE view. A1 and A2 are trivial paravalvular leaks, whereas B is a trivial central regurgitation, all of which are negligible. C is a more severe paravalvular leak, which was ameliorated by a second valve inflation. Ao indicates aorta; AR, aortic regurgitation; LA, left atrium; and LV, left ventricle. The Annals of Thoracic Surgery 2012 93, 1340-1395DOI: (10.1016/j.athoracsur.2012.01.084) Copyright © 2012 The Society of Thoracic Surgeons, the American College of Cardiology Foundation, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions Terms and Conditions

Fig 8 Severe AR. Long-axis TEE view showing severe AR following TAVR deployment (Panel A), confirmed by flow reversal in the descending aorta (Panel B). Short axis imaging (Panels C and D) demonstrates that this is due to failure of the leaflet in the left coronary position (arrow) to close in diastole, ultimately treated by deploying a second valve inside this one. Ao indicates aorta; AR, aortic regurgitation; LA, left atrium; and LV, left ventricle. The Annals of Thoracic Surgery 2012 93, 1340-1395DOI: (10.1016/j.athoracsur.2012.01.084) Copyright © 2012 The Society of Thoracic Surgeons, the American College of Cardiology Foundation, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions Terms and Conditions